Welcome to our dedicated page for Archimedes Tech SPAC Partners II Co. SEC filings (Ticker: ATII), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking a SPAC like Archimedes Tech SPAC Partners II Co. (ATII) means wading through disclosures on trust balances, warrant dilution and looming deadlines. If you have ever opened its 200-page registration statement looking for one chart, you know the pain.
Stock Titan resolves that problem instantly. Our AI digests every ATII document the moment it lands on EDGAR and delivers pinpoint answers. Need the latest Archimedes Tech SPAC Partners II Co. insider trading Form 4 transactions? They are flagged in real time, so you can see sponsor redemptions or new purchases. Wondering how cash per share has changed? The platform links that metric to the Archimedes Tech SPAC Partners II Co. quarterly earnings report 10-Q filing—no manual scrolling required.
Each filing type is mapped to the questions investors actually ask about SPACs:
- Archimedes Tech SPAC Partners II Co. 8-K material events explained so you can spot a signed merger agreement the same day.
- Archimedes Tech SPAC Partners II Co. annual report 10-K simplified with AI, highlighting trust expiration dates.
- Archimedes Tech SPAC Partners II Co. proxy statement executive compensation breakdowns before a shareholder vote.
- Archimedes Tech SPAC Partners II Co. Form 4 insider transactions real-time alerts for sponsor stock moves.
By understanding Archimedes Tech SPAC Partners II Co. SEC documents with AI, you can:
- Compare dilution scenarios across warrants and rights.
- Monitor redemption pressure ahead of a deal.
- Evaluate management incentives through Archimedes Tech SPAC Partners II Co. executive stock transactions Form 4.
- Dive into Archimedes Tech SPAC Partners II Co. earnings report filing analysis without poring over footnotes.
The result: Archimedes Tech SPAC Partners II Co. SEC filings explained simply, updated the second they post, so you can act on facts, not guesswork.
Archimedes Tech SPAC Partners II Co. reported Q3 2025 results highlighting interest-driven income and a strong trust balance. Net income was $2,403,801 for the quarter, primarily from $2,546,478 of interest earned on the Trust Account, offset by $159,842 of general and administrative expenses.
As of September 30, 2025, the Trust Account held $237,491,299 and cash outside the trust was $1,409,116. The company completed its IPO on February 12, 2025, selling 23,000,000 units at $10.00 per unit (including the full 3,000,000 over-allotment), for $230,000,000 in gross proceeds, and a concurrent private placement of 840,000 units for $8,400,000. A deferred underwriting fee of $8,050,000 remains payable upon a business combination.
Ordinary shares subject to possible redemption totaled 23,000,000 at a redemption value of $10.33 per share as of September 30, 2025. Warrants outstanding were 11,920,000, each whole warrant exercisable at $11.50 per share under stated conditions. As of November 7, 2025, there were 29,590,000 ordinary shares issued and outstanding.